Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics hypoxia inducible factors'

Search results for: 'research area epigenetics hypoxia inducible factors'

Items 1-10 of 22

Page
per page
  1. Bardoxolone methyl
    A3221 Bardoxolone methyl
    Target: Nrf2
    Summary: IKK inhibitor, potent antioxidant inflammation modulator
      ≥25.3 mg/mL
  2. AZD1480
    A4137 AZD1480
    Target: JAK
    Summary: JAK2 inhibitor,ATP-competitive and novel
      insoluble in H2O; ≥93.8 mg/mL
  3. Lestaurtinib
    A4513 Lestaurtinib
     1 Citation
    Summary: JAK2/FLT3/TrkA inhibitor
      Soluble in DMSO
  4. CYT387 sulfate salt
    A3339 CYT387 sulfate salt
    Summary: JAK1/JAK2 inhibitor
      Soluble in DMSO
  5. Ruxolitinib phosphate
    A3781 Ruxolitinib phosphate
    Summary: JAK1/JAK2 inhibitor
      ≥20.2 mg/mL
  6. WHI-P97
    A3936 WHI-P97
    Summary: Janus kinase (JAK)-3 inhibitor
      Soluble in DMSO
  7. Ruxolitinib (INCB018424)
    A3012 Ruxolitinib (INCB018424)
     4 Citation
    Target: JAK
    Summary: JAK inhibitor
      insoluble in H2O; ≥15.32 mg/mL
  8. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  9. CYT387
    A4143 CYT387
     1 Citation
    Summary: JAK-1/-2 inhibitor,ATP competitive
      insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL
  10. CEP-33779
    A4146 CEP-33779
     1 Citation
    Summary: JAK2 inhibitor,highly selective
      ≥23.15 mg/mL

Items 1-10 of 22

Page
per page